Cecelia Health, Inc.

Cecelia Health, Inc. is a virtual specialty medical practice that focuses on comprehensive cardiometabolic care, offering integrated support for chronic conditions through innovative virtual healthcare solutions. Founded in 2007 and headquartered in New York, US, Cecelia Health, Inc. operates as a virtual specialty medical practice that provides comprehensive care for chronic conditions.

The company raised USD 13. 00 mn in Series B funding on August 13, 2020, co-led by Rittenhouse Ventures and Endo Investors, along with contributions from Boston Millennia Partners, SustainVC, and G100 Capital. Dainius Adomaitis, David Weingard, and Mark Clermont serve as the CEOs. Cecelia Health has been involved in 9 deals to date.

Cecelia Health operates as a virtual specialty medical practice focusing on comprehensive cardiometabolic care. Their core offerings include integrated clinical support for managing chronic conditions such as obesity, diabetes, hypertension, kidney disease, and respiratory issues. The company emphasizes a coordinated approach that combines virtual clinical support and education, medication management, remote monitoring, medical nutrition therapy, and clinical-grade lifestyle interventions. Cecelia Health targets individuals in need of multidisciplinary care as well as healthcare providers and pharmaceutical partners looking for improved patient management solutions.

Their services are primarily available in the United States, with an aspiration to expand to other markets in the future. Cecelia Health generates revenue through a B2B model, partnering with healthcare providers and pharmaceutical companies to deliver comprehensive care solutions. The company employs a subscription-based pricing structure for its clinical services, enabling clients to access ongoing support and resources tailored to managing chronic conditions. The firm also offers specific programs like GLP-1 clinical support, which aids patients in achieving weight loss and managing their medications effectively.

Transactional relationships are established with healthcare organizations utilizing Cecelia Health's services to enhance patient care and improve outcomes for their populations. In August 2020, Cecelia Health, Inc. raised USD 13. 00 mn in Series B funding, which will be utilized to support the development of new products and expansion into new markets.

The company aims to enhance its offerings and reach a broader audience by targeting specific regions for growth, although detailed plans on upcoming product launches or specific markets have not been disclosed. The latest funding round will play a critical role in advancing these initiatives.